Hans-Martin Jäck is a Professor for Immunology and the director the Division of Molecular Immunology at the University of Erlangen, Germany. His research focuses on B cell immunology, specifically on the generation of therapeutic human antibodies against multiple myeloma in a transgenic mouse platform expressing the entire human antibody repertoire and the development of mature B cells into effector cells (memory B- and plasma cells).
In this interview Prof Jäck discusses his contribution to B cell immunology.
Interview by Rebecca Chukwuanukwu
